Subject Matter

Whether an unresolved, circumstantial suspicion of commercial motive should override a facially genuine act of altruistic organ donation, given the law’s mandate to prevent exploitation without needlessly obstructing legitimate donation.

Facts

• THOTA, 1994 permits unrelated living donation only where proven free of commercial transaction
• Kavita Nair’s stated motive: reciprocal altruism — “paying forward” kindness she once received
• A Committee member flags a coincidental debt repayment by Kavita’s family around the same time — no documentary link to the recipient’s family
• The recipient’s condition is worsening; delay reduces transplant success chances
• India’s transplant gap is severe: roughly 200,000 needing kidney transplants annually against under 14,000 transplants performed

Values/Principles Involved

• Autonomy (Kantian) — respecting Kavita’s capacity as a rational agent to freely choose an act of self-sacrifice, not treating her as a suspect by default
• Supererogatory altruism — an act exceeding the call of duty, praiseworthy precisely because it is freely chosen, not obligatory
• Non-maleficence toward the vulnerable — the law’s caution exists because unrelated donation has been the historical route for organ trafficking, exploiting the poor and desperate
• Utilitarian calculus — weighing the aggregate benefit of enabling a life-saving transplant against the systemic risk of normalising commercial donation if this case is, in fact, disguised trade
• Distributive justice (Rawlsian) — India’s acute organ shortage falls hardest on patients without near-relative donors, who are disproportionately from families lacking social and financial capital
• Burden of proof and presumption — whether the Committee’s institutional posture should presume innocence (facilitating altruism) or presume risk (guarding against commodification) when evidence is genuinely ambiguous

Stakeholders

• Kavita Nair, the prospective donor, and her stated motivations
• The recipient, whose deteriorating health is time-sensitive
• The dissenting Committee member, upholding the law’s protective intent
• Future donors and recipients, affected by whatever precedent this decision sets
• The organ donation ecosystem’s credibility as a whole
• Dr. Meera Iyer, as a deciding member of the Committee

(a) Ethical Considerations to Guide the Committee

• Distinguish coincidence from causation: a debt repayment occurring around the same time is a temporal correlation, not evidence of a transactional link — ethical decision-making requires the Committee to avoid what is, in essence, a fallacy of assumed causation dressed up as due diligence
• Apply the “noxious market” test precisely, not by analogy: political philosopher Debra Satz’s account of noxious markets identifies commercial organ trade as harmful because it thrives on desperation, informational asymmetry, and unequal risk distribution — the Committee should ask whether these specific conditions are present here, rather than treating any unrelated donation as presumptively suspect
• Respect donor autonomy as a starting point, not an afterthought: under a Kantian framework, treating Kavita merely as a potential fraud to be caught, rather than as a rational agent capable of genuine moral choice, risks failing to treat her as an end in herself
• Weigh institutional caution against the cost of excessive suspicion: India’s already documented pattern — genuine unrelated donors facing years-long bureaucratic struggles due to unfamiliarity and institutional distrust — shows that over-caution has a real, if less visible, victim: the deserving recipient who dies waiting while a legitimate donor is delayed

(b) Ethical Dilemmas Faced by Dr. Meera

• Autonomy vs Paternalism — respecting Kavita’s stated free choice versus the Committee’s protective duty to look beyond her stated word
• Speed vs Accuracy — the recipient’s worsening condition presses for a quick decision, while genuine due diligence on the debt-repayment coincidence takes time the recipient may not have
• Individual Justice vs Systemic Precaution — treating this specific case on its own facts versus the wider institutional need to hold a firm line against commercial organ trade generally
• Means vs Ends — even if approving the donation produces a good outcome (a life saved), the decision must be reached through a process that remains defensible under THOTA’s evidentiary standard, not simply because the outcome feels right
• Institutional Duty vs Humanistic Perspective — the Committee’s statutory mandate to prevent exploitation pulls against the human cost of doubting a donor who may be entirely genuine

(c) Should the Committee Approve or Delay? — Approve, With a Documented, Time-Bound Verification Process Running in Parallel

• The evidence available does not meet even a reasonable threshold of suspicion — a coincidental debt repayment, without any documentary or testimonial link to the recipient’s family, is circumstantial at best; treating mere coincidence as disqualifying would set a precedent where any unrelated donor with an unrelated financial event in their life becomes suspect, which is neither a workable nor a fair standard
• Outright rejection or indefinite delay imposes a certain, serious harm (the recipient’s declining health) to guard against an unproven, speculative harm (a hypothetical hidden transaction) — this asymmetry matters ethically, especially where the recipient’s clock is running
• A parallel process protects both values: the Committee can approve the donation based on the totality of the interview evidence and Kavita’s documented consent process, while simultaneously directing a time-bound, targeted financial verification (bank records, any communication trail) to run alongside the transplant process, ensuring that if a genuine commercial link is later established, the law’s penal provisions can still be invoked
• This avoids the false binary between blind approval and paralysing suspicion, treating the Committee’s role as one of proportionate diligence, not maximal risk-aversion at the expense of a dying patient and a sincere donor

Way Forward

The law’s caution around unrelated donation exists to protect the vulnerable from exploitation — not to make genuine altruism indistinguishable from suspected crime. A Hospital Authorisation Committee that treats every unrelated donor as a probable fraud, absent real evidence, ends up punishing exactly the kind of moral courage the law should be protecting, while a recipient’s life hangs in the balance. The ethical standard is proportionate scrutiny, not presumed guilt — verification should run alongside compassion, not in place of it.